Market Research Reports
Resources
About
Cart (0)

Medical Robotics and Computer-Assisted Surgery

Report Code: HLC036C

Publish Date: Jun 2009

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The U.S. market for medical robotics and computer-assisted surgical equipment was worth an estimated $648 million in 2008. The market is projected to reach $676 million in 2009 and $1.5 billion by 2014, a CAGR of 17.7%.
  • Surgical robot systems were the largest product segment of the market in 2008 with a 54% market share. With a projected average annual growth rate of more than 23% between 2009 and 2014, surgical robots are expected to increase their share of the US MRCAS market to 65% by 2014.
  • In terms of surgical applications, orthopedic surgical applications are projected to grow at a CAGR of 42.6% between 2009 and 2014, and are expected to account for 22% of the market by 2014.

INTRODUCTION

MEDICAL ROBOTICS AND COMPUTER-ASSISTED SURGERY
 
Information technology plays a key role in an ever-widening range of human activities, including surgery. Computers, working in tandem with a variety of microprocessor-enabled equipment and instruments, support and facilitate the work of the surgeon and have brought a level of safety and precision to surgery that would have been inconceivable just a few years ago. 
These computers, electronic equipment, and instruments are referred to collectively as medical robotics and computer-assisted surgery (MRCAS) or, more dramatically, “the Operating Room of the Future.” Their intended function is not to replace the surgeon, but to support the surgeon with enhanced dexterity, visual feedback, and information integration.
STUDY GOAL AND OBJECTIVES 
This BCC study analyzes U.S. and global markets for MRCAS equipment in the light of the most recent available information. In addition to looking at current and future markets for these devices, the study will analyze technological, economic, and regulatory developments that may have a long-term impact on the size and structure of the MRCAS market.
More specific objectives are to:
  • Identify and segment the main types of MRCAS devices that have been commercialized to date.
  • Analyze the historical and current volume and value of shipments of each of these product segments in specified applications and geographical markets.
  • Identify and evaluate the impact of demographic, economic, and other factors that will drive future demand for MRCAS devices.
  • Forecast the volume and value of product shipments by equipment type and application and probabilities that future demand will be higher or lower than the baseline forecast.
  • Identify promising new surgical procedures and products still in the development and testing stage and assess the probability that they will be commercialized successfully in the next 5 years,
  • Forecast the potential market for these developmental procedures and products, taking into account the estimated probability that they will be commercialized.
  • Identify leading manufacturers of the devices and analyze the structure of the MRCAS industry (e.g., market shares, concentration, and recent M&A activity).
  • Assess the long-term outlook for MRCAS equipment, taking into account market opportunities as well as technological, financial, and economic factors. 
REASONS FOR DOING THE STUDY
 
MRCAS is used in a growing number of operating rooms around the world, largely as a result of the growing popularity of minimally invasive surgical (MIS) techniques. Minimally invasive, or “keyhole,” surgery is an alternative to traditional open-incision surgery in a growing number of procedures. MIS utilizes special instruments that can be inserted and manipulated through small incisions (sometimes no more than a few millimeters long) under remote optical or video guidance, greatly reducing patient trauma and recovery times.
The need to perform delicate surgical procedures, safely, in tight spaces where the surgeon cannot see directly, has created a growing market for devices that act as extensions of the surgeon’s eyes and hands: remote imaging, data processing and feedback, and robotics. This market is already estimated at more than half a billion dollars annually and is growing faster than the overall surgical equipment market.
Because the use of these products is increasing so rapidly, there is a pressing need to develop and maintain an up-to-date base of market information in order to better understand the dynamics of the market for MRCAS devices and equipment. Several research reports on the medical robotics and computer-assisted surgical market are in print, but all are based on research that is two or more years old, a relatively long time in such a fast-moving field. One of the two most recent reports is a briefer, less in-depth report than the present study.
Meanwhile, MRCAS technology has been evolving, as have the medical and economic environments in which it is used. Populations are aging, increasing demand for a wide range of age-related surgical procedures such as heart and orthopedic surgery. Technological advances have expanded the range of surgical procedures that can be performed using minimally invasive techniques, making them accessible to even more people.
The structure of the hospital industry, the main user of MRCAS, is changing, as hospitals consolidate and other health care options such as walk-in surgical clinics become available to consumers. Private and government health insurers around the world are becoming more cost-conscious, forcing hospitals to re-evaluate their capital spending plans but strengthening the case for technologies that can reduce the cost of surgical procedures. Medical malpractice suits continue to be common in markets like the United States, and technologies that increase the precision and accuracy of surgery have obvious appeal. This report attempts to give management readers the information and analysis they need to understand and deal with these issues.
INTENDED AUDIENCE 
This report provides an analysis of the market for MRCAS by type of surgical procedure, device, and region. The future of MRCAS equipment will also be discussed, with forecasts for consumption of specific products.
This report has been written for the entire MRCAS interest community but is tailored especially for readers with an interest in the marketing and management dimensions of MRCAS equipment, especially those in:
  • The medical and surgical devices industry
  • Medical research institutions
  • Investors
  • The financial and analyst community
 SCOPE OF REPORT 
This report is an analytical business tool whose primary purpose is to describe the MRCAS equipment industry and the global market for these devices. MRCAS equipment is defined as computer- or microprocessor-enabled devices and accessories that are physically situated in the operating room and directly assist the surgeon in planning and carrying out surgical procedures. Thus, the scope of the study does not include:
  • Devices that provide images and other information but are not an integral part of the MRCAS system such as preoperative imaging (e.g., computed tomography (CT), magnetic resonance imaging (MRI)) equipment, laboratory and other analytical devices
  • Computerized medical records systems
  • Electronic operating room equipment such as heart monitors that enable the surgical team to monitor the patient’s condition but do not assist the surgeon directly in carrying out the operation
  • Other nonelectronic operating room equipment
The format of the study is organized around the following topics:
  • Major types and applications of MRCAS
  • Industry structure
  • Market size and segmentation, including historical data on sales by application, product type, and geographical market
  • Market drivers
  • Detailed market projections through 2014
  • Competition and market shares
  • Observations and conclusions regarding the future of the MRCAS market
 METHODOLOGY AND INFORMATION SOURCES
The findings and conclusions of this report are based on information gathered from manufacturers and users of MRCAS and other informed sources. Interview data was combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature, and online databases to produce the baseline market estimates contained in this report.
The base year for analysis and projection is 2008. With 2008 as a baseline, market projections were developed for 2009 to 2014. The market projections are “consensus” projections, obtained by averaging market scenarios obtained from industry and other sources or developed independently by BCC. The analytical methodologies BCC used to generate the market estimates are described in detail in the section on detailed market projections.
All dollar projections presented in this report are in 2008 constant dollars. 
ANALYST CREDENTIALS
 
The author of this report is Andrew McWilliams. Mr. McWilliams, a partner in the Boston-based international technology and marketing consulting firm of 43rd Parallel, LLC, is the author of several other Business Communications Company studies of the surgical and related medical devices markets, including: The Market for Minimally Invasive Medical Devices (HLC051E); Patient Monitoring (HLC038C); Global Medical Markets for Nanoscale Materials and Devices (HLC058A); and Microelectronic Medical Implants: Products, Technologies, and Opportunities (HLC016C).
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of market research reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER
 
The information developed in this report, is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is of a speculative nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Medical Robotics and Computer-Assisted Surgery152Free
Chapter- 1: INTRODUCTION5Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: OVERVIEW OF MEDICAL ROBOTICS AND COMPUTER-ASSISTED SURGERY87Free
Chapter- 4: THE U.S. MARKET FOR MRCAS EQUIPMENT32Free
Chapter- 5: INTERNATIONAL MARKETS FOR MRCAS5Free
Chapter- 6: VENDOR PROFILES21Free
Published - Jul-2006| Analyst - Andrew McWilliams| Code - HLC036B

Report Highlights

  • The U.S. market for medical robotics and computer-assisted surgical equipment was worth an estimated $564 million in 2005. The market is projected to reach $704 million in 2006 and $2.8 billion by 2011, an average annual growth rate (AAGR) of 31.4%.
  • Surgical navigation systems were the largest product segment (53%) of the U.S. MRCAS market in 2005. However, surgical robots are the fastest growing U.S. market segment, with a projected AAGR of over 43% between 2006 and 2011.
  • In terms of surgical applications, neurosurgical applications accounted for the bulk of the U.S. MRCAS market-approximately 40%-in 2005. Endoscopic surgical applications are the fastest-growing application segment, and are expected account for a market-leading 45% of the U.S. market by 2011.
  • The total worldwide market for MRCAS devices and equipment is expected to be $1.3 billion in 2006 and $5.7 billion by 2011, an AAGR of 34.7%.

Published - Jun-2003| Analyst - Andrew McWilliams| Code - HLC036A

Report Highlights

  • U.S. MRCAS market will grow at more than 22% annually on average reaching $673 million by 2007.
  • Surgical robots are the fastest-growing U.S market segment.
  • Sales of surgical robots should reach $220 million in 2007.
  • Endoscopic surgical applications are the fastest-growing application segment.

Related Reports

Recent Reports

Conventional and Alternative Pain Treatment Markets

Published - Nov 2024 | Publisher - Partha Sarathi Das | Code - HLC266B

The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

CRISPR Technology: Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC258C

The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC239C

The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - Partha Sarathi Das | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Top Trending Reports

AI in Clinical and Molecular Diagnostics Market

Published - Oct 2024 | Publisher - BCC Publishing | Code - BIO261A

The global market for AI in clinical and molecular diagnostics is expected to grow from $2.6 billion in 2024 and is projected to reach $8.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 27.6% during the forecast period of 2024 to 2029.

Point-of-Care Diagnostics: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC043H

The global market for point-of-care diagnostics was valued at $36.9 billion in 2023. It is expected to grow from $40.6 billion in 2024 to $65.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% from 2024 through 2029.

Medical Devices: Technologies and Global Markets

Published - Oct 2024 | Publisher - BCC Publishing | Code - HLC170F

The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.

Global Artificial Intelligence (AI) Market: Investments vs Potential

Published - Aug 2024 | Publisher - BCC Publishing | Code - IFT189C

The global market for artificial intelligence (AI) is estimated to increase from $148.8 billion in 2023 to reach $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 39.7% from 2024 through 2029.

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Medical Robotics and Computer-Assisted Surgery
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.
Contact
© 2024 BCC Research
Privacy Policy |Site Map|Terms & Conditions